Clin2
NCT05832606Possibly a fitRecruiting

Food changes to reduce side effects from immunotherapy

Immune-related Adverse EventDietary Habits

Part of Immune system & allergy clinical trials.

This trial tests whether a specific food plan can reduce side effects (toxicity) from standard immunotherapy that targets PD-1 and/or CTLA-4. It may help people tolerate treatment better while staying on their usual cancer care.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
60 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You have a solid tumor and are starting PD-1 and/or CTLA-4 immunotherapy as standard treatment
  • You can sign a consent form to join the study
  • You can eat and drink by mouth during the study
  • You are either not using probiotics, or you are willing to stop them during the trial
  • Your cancer treatment plan does not include chemotherapy or targeted medicines combined with the immunotherapy

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06438588Recruiting
Fasting-mimicking diet to reduce immunotherapy side effects

This trial tests whether a special low-calorie 'fasting-mimicking' diet can reduce side effects from common immunotherapy drugs for advanced cancer. If you're on a PD-1, PD-L1, or CTLA-4 inhibitor, this diet might help you feel better during treatment.

Jacksonville, Florida
NCT06475807Recruiting
Dietary changes for people on immunotherapy for cancer

This study tests whether a change in diet can help people with early-stage melanoma or lung cancer who are receiving immunotherapy (a type of treatment that helps your immune system fight cancer). You will be asked to follow a diet, give blood and stool samples, and complete questionnaires to see how the diet affects your body and treatment.

Pittsburgh, Pennsylvania
NCT05356182Recruiting
Low-protein meals during immunotherapy for cancer patients

This trial tests whether eating low-protein meals helps people with metastatic cancer feel better or tolerate immunotherapy (immune checkpoint inhibitors). It’s mainly a pilot/feasibility study, meaning the goal is to see if the diet is safe and doable during treatment.

Buffalo, New York
NCT05805319Recruiting
Food intervention for people with lung cancer on immunotherapy

This trial studies whether a specific diet can help people with non-small cell lung cancer who are receiving immunotherapy (a standard cancer treatment). It mainly checks whether participants can follow the diet plan and tolerate the food changes safely.

Montreal, Quebec
NCT06466434Recruiting· Phase 2
Prebiotic diet to boost immunotherapy for melanoma

This trial tests whether a special prebiotic diet can help your body's bacteria (microbiome) better respond to standard immunotherapy for advanced melanoma that cannot be removed by surgery. If you are starting your first immunotherapy, you may be able to join.

Houston, Texas
NCT06736678Recruiting
Nutritional drink to reduce side effects from pancreatic cancer treatment

This trial tests a special nutritional drink (oral immunonutrition) to see if it can reduce side effects from chemotherapy and radiation in people with pancreatic cancer. It may help you feel better during treatment if you are at risk for malnutrition.

Guangzhou, Guangdong

Hear when a new Immune-related Adverse Event trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.